Mirum Pharmaceuticals, Inc. (MIRM)
93.54
-3.43
(-3.54%)
USD |
NASDAQ |
Nov 05, 16:00
93.07
-0.47
(-0.50%)
After-Hours: 20:00
Mirum Pharmaceuticals SG&A Expense (TTM) : 251.93M for Sept. 30, 2026
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
| Date | Value |
|---|---|
| September 30, 2026 | 251.93M |
| June 30, 2026 | 313.84M |
| March 31, 2026 | 295.65M |
| December 31, 2025 | 257.03M |
| September 30, 2025 | 239.73M |
| June 30, 2025 | 228.37M |
| March 31, 2025 | 214.29M |
| December 31, 2024 | 202.22M |
| September 30, 2024 | 191.58M |
| June 30, 2024 | 177.56M |
| March 31, 2024 | 161.30M |
| December 31, 2023 | 145.88M |
| September 30, 2023 | 126.16M |
| June 30, 2023 | 112.15M |
| March 31, 2023 | 100.17M |
| December 31, 2022 | 89.07M |
| Date | Value |
|---|---|
| September 30, 2022 | 81.63M |
| June 30, 2022 | 76.47M |
| March 31, 2022 | 68.86M |
| December 31, 2021 | 59.22M |
| September 30, 2021 | 47.41M |
| June 30, 2021 | 35.79M |
| March 31, 2021 | 27.48M |
| December 31, 2020 | 22.69M |
| September 30, 2020 | 19.74M |
| June 30, 2020 | 17.72M |
| March 31, 2020 | 15.12M |
| December 31, 2019 | 11.75M |
| September 30, 2019 | 7.474M |
| June 30, 2019 | 3.766M |
| March 31, 2019 | 1.321M |
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Incyte Corp. | 1.435B |
| Insmed, Inc. | 960.24M |
| Galectin Therapeutics, Inc. | 6.712M |
| TG Therapeutics, Inc. | 296.46M |
| Kodiak Sciences, Inc. | 45.82M |